1. SIFIDE Framework and Operation

SIFIDE, established by Decree-Law no. 292/2002, of 15 November, and currently regulated by the Investment Tax Code (CFI), approved by Decree-Law no. 162/2014, of 31 October, in its current wording, is one of the most powerful instruments for incentivising innovation in Portugal. It is a tax credit that rewards companies investing in research and development (R&D) – that is, in the creation of new products, processes, software, technologies, or the significant improvement of existing ones. Unlike a deduction from taxable profit, SIFIDE is deducted directly from the IRC liability, meaning its value reduces the tax payable by the company euro for euro. This mechanism makes it particularly attractive, as the benefit is felt immediately and directly in the tax settlement. It is especially valuable for technology, software, biotechnology, industrial companies, and startups in a growth phase with intensive investment in innovation.

1.1. What is understood by Research and Development (R&D)

For SIFIDE purposes, and in accordance with the OECD Frascati Manual guidelines, the following are considered:

• Scientific Research: The acquisition of new fundamental scientific or technical knowledge, without a specific commercial application in mind.
• Experimental Development: The application of existing scientific and technical knowledge in the creation or significant improvement of materials, products, processes, systems, or services.

2. Calculation Mechanism and Value of the Tax Benefit

The value of SIFIDE is determined by applying two distinct rates to eligible R&D expenses, as established in Article 36 of the Investment Tax Code.

2.1. Components of the Tax Credit

2.2. Practical Example of SIFIDE Benefit Calculation

Let's consider a company "TecnoInova, S.A." with the following R&D expense data:

• R&D expenses in year N-2: €100,000
• R&D expenses in year N-1: €150,000
• R&D expenses in year N (application year): €300,000
• IRC liability in year N: €80,000

Calculation:

1. Average R&D expenses in the two previous years (N-2 and N-1):
   (€100,000 + €150,000) / 2 = €125,000
2. Increase in R&D investment in year N compared to the average:
   €300,000 - €125,000 = €175,000
3. Calculation of the base rate benefit:
   32.5% * €300,000 (R&D expenses year N) = €97,500
4. Calculation of the incremental rate benefit:
   The increase of €175,000 is within the €1,500,000 limit.
   50% * €175,000 (increase) = €87,500
5. Total SIFIDE Tax Credit:
   €97,500 (base rate) + €87,500 (incremental rate) = €185,000
6. Deduction from IRC Liability:
   The company has an IRC liability of €80,000. It can deduct €80,000 from the SIFIDE credit.
7. Reportable SIFIDE Credit:
   €185,000 (total SIFIDE) - €80,000 (deducted in year N) = €105,000.

The remaining €105,000 can be carried forward and deducted from the IRC liability in the following 8 tax years, as provided for in Article 36, no. 6, of the Investment Tax Code.

2.3. Carry-forward of the Tax Credit

The calculated amount is deducted from the IRC liability in Form 22. The portion that cannot be deducted in one year (due to insufficient liability) is carried forward for up to 8 subsequent tax years. This carry-forward mechanism is fundamental for companies in early stages or with variable profitability, ensuring that the benefit is not lost and can be used when the company generates sufficient taxable profit.

3. Eligible Expenses for SIFIDE

The eligibility of expenses is a critical aspect for the correct application of SIFIDE. Article 36, no. 3, of the Investment Tax Code details the categories of expenses considered eligible, provided they are directly related to R&D activities:

• Personnel expenses assigned to R&D: Includes salaries, wages, and other remuneration (including mandatory social charges) of researchers, engineers, programmers, and other qualified technicians, in proportion to the time spent on R&D activities. This is one of the most significant and impactful categories.
• Acquisition of tangible fixed assets: Excluding buildings and land, provided they are exclusively dedicated to R&D activities. Examples include laboratory equipment, specific prototyping machines, or specialised software.
• Operating expenses: Include general management expenses, materials, supplies, and external services that are directly attributable to R&D activities. These expenses are eligible up to a maximum of 20% of personnel expenses assigned to R&D.
• Contracting R&D: Expenses for contracting R&D activities from other entities, whether public entities (universities, state laboratories) or private entities (technology centres, other companies), provided they are duly certified or recognised as suitable for this purpose.
• Registration and maintenance of patents, models, and industrial designs: Expenses related to the protection of intellectual property resulting from R&D activities, including registration fees and associated consulting costs.
• Acquisition of patents: Provided they are acquired from entities unrelated to the company and are used exclusively in R&D activities.
• Expenses for R&D audits: Costs for the certification or audit of R&D activities and expenses by independent entities.

It is essential that the company maintains rigorous and detailed documentation proving the R&D nature of each expense, including project descriptions, personnel time records, invoices, and contracts.

4. Application Process and Deadlines

Managing the SIFIDE application process requires attention to detail and strict adherence to deadlines, with the National Innovation Agency (ANI) being responsible for the technical validation of projects.

4.1. Responsible Entity

The application is submitted electronically to ANI – Agência Nacional de Inovação (National Innovation Agency). ANI's role is to analyse and validate the R&D nature of the projects submitted, issuing a declaration that certifies the eligibility of the activities and expenses. This declaration is indispensable for the company to make the deduction in its IRC Form 22.

4.2. Application Deadlines

The deadline for submitting the application is, as a general rule, by the end of May of the year following that of the R&D expenses. For example, R&D expenses incurred in 2025 must be applied for by May 2026. It is crucial to respect this deadline to ensure access to the tax benefit. The exact deadline is communicated annually by ANI.

4.3. Documentation and Best Practices

It is fundamental to thoroughly document R&D projects and expenses throughout the year. Good practice includes:

• Project Sheets: Detailing objectives, methodologies, phases, expected results, and the team involved.
• Time Records: Maintaining detailed records of hours dedicated by each team member to R&D projects.
• Contracts and Invoices: Organised archiving of all supporting documents for eligible expenses.
• Technical Reports: Description of progress and results obtained in each phase of the project.

Robust documentation not only facilitates the validation process by ANI but also serves as support in case of a tax inspection, mitigating the risk of challenge by the Tax and Customs Authority.

5. SIFIDE in Context: Compatibility with Other Tax Benefits

SIFIDE, as an R&D incentive, is designed to be compatible with other support schemes, maximising the benefit for innovative companies. The general rule is that the cumulation of tax benefits is allowed, provided it does not apply to the same expenses.

5.1. SIFIDE and ICE (Incentive for Company Capitalisation)

SIFIDE is compatible with the ICE (Incentive for Company Capitalisation), provided for in Article 43 of the Tax Benefits Statute (EBF). ICE allows companies to deduct a percentage of net increases in equity from their taxable profit. The compatibility is full, as SIFIDE applies to R&D expenses and ICE applies to company capitalisation; that is, they are benefits of a different nature and basis of incidence. For a software company, for example, that capitalises and invests in R&D, the combination of these two incentives can drastically reduce the IRC payable.

5.2. SIFIDE and Other Incentives

Compatibility extends to most existing tax benefits and financial incentives. The non-cumulation rule only applies when the benefits relate to the same eligible expenses. For example, if an R&D expense is co-financed by European funds (e.g., Portugal 2030), the non-co-financed portion of the expense may be eligible for SIFIDE. Similarly, if a company benefits from an R&D "cash-back" scheme, it must ensure that the expenses eligible for SIFIDE are not the same as those that were subject to another benefit.

This flexibility allows companies to optimise their tax burden and maximise the return on their innovation investments, provided there is correct segregation and identification of expenses for each scheme.

6. Common Mistakes to Avoid in SIFIDE Applications

Despite being a very advantageous benefit, the complexity of SIFIDE and the need for rigour in documentation can lead to errors that compromise its attribution. Knowing the most common mistakes is crucial for a successful application:

1. Lack of R&D Characterisation: Presenting activities that do not qualify as R&D under the Frascati Manual. Routine activities, process optimisation without technological novelty, or simple adaptation of existing technologies are often disqualified. It is essential to demonstrate novelty, uncertainty, and systematicity.
2. Insufficient or Disorganised Documentation: The absence of personnel time records, technical descriptions of projects, progress reports, or detailed invoices prevents the validation of expenses. ANI requires robust proof of the execution and eligibility of activities and expenses.
3. Ineligible Expenses: Including expenses not expressly provided for in Article 36 of the CFI, such as commercialisation expenses, marketing, or the acquisition of buildings and land. It is also common to include personnel expenses not directly assigned to R&D.
4. Failure to Meet Deadlines: Submitting the application after the established deadline (usually the end of May of the year following the expenses) results in its automatic exclusion, regardless of project quality.
5. Failure to Segregate Expenses (in case of cumulation): If the company benefits from other incentives for the same activities, failing to correctly segregate expenses between different schemes can lead to the rejection of SIFIDE or the obligation to repay benefits.
6. Incorrect Estimation of Personnel Hours: The allocation of personnel hours must be based on reliable records (timesheets, logbooks) and not on estimates. ANI may request evidence of how hours were calculated.
7. Ignoring the Need for Continuous Monitoring: R&D documentation is not an annual process but a continuous one. Projects should be monitored, and expenses recorded as they occur, facilitating the preparation of the application and responding to any information requests.

7. Relevant Legal References

The legal basis of SIFIDE is fundamental for its correct application and understanding. Key references include:

• Decree-Law no. 162/2014, of 31 October (Investment Tax Code - CFI): This legal diploma establishes the legal regime of SIFIDE, specifically in its Article 36, which details the eligibility conditions, applicable rates, eligible expenses, and the carry-forward of the tax credit. It is the main source of consultation for applying the benefit.
• Decree-Law no. 292/2002, of 15 November: Diploma that instituted SIFIDE, although its provisions have since been integrated and updated in the CFI.
• Ordinance no. 345-A/2014, of 31 December: This Ordinance regulates various aspects of the CFI, including procedures and requirements for submitting SIFIDE applications.
• Tax Benefits Statute (EBF): Although SIFIDE is in the CFI, the EBF (approved by Decree-Law no. 215/89, of 1 July, and its amendments) contains general provisions on tax benefits that may be subsidiarily applicable, such as rules on expiry or carry-forward of tax credits (e.g., Article 43 for ICE, which is compatible).
• Corporate Income Tax Code (CIRC): The CIRC (approved by Decree-Law no. 442-B/88, of 30 November, and its amendments) establishes the general rules for calculating the IRC liability, with SIFIDE being a tax credit to be deducted from this liability. Article 90 of the CIRC deals with deductions from the liability.

Regular consultation of these diplomas and any rulings or binding information from the Tax and Customs Authority and the National Innovation Agency is crucial to ensure compliance and maximise the benefit.

8. HVR's Role in Optimising SIFIDE

The complexity of SIFIDE, from the correct identification of R&D activities to the preparation of documentation and submission of the application, requires in-depth knowledge and rigorous management. HVR Business Consulting offers specialised services for companies aiming to maximise their SIFIDE benefit securely and efficiently.

8.1. How HVR Helps

• Eligibility Analysis: Preliminary assessment of the company's activities to identify projects and expenses with potential for eligible R&D.
• Monitoring and Documentation: Guidance and support in organising technical and financial documentation throughout the year, ensuring all ANI requirements are met. This includes structuring project sheets, time records, and documentary proof of expenses.
• Application Preparation and Submission: Preparation of the technical and financial application, ensuring all information is presented clearly, completely, and in accordance with ANI's requirements. Submission of the application within the established deadlines.
• Deduction in Form 22: After ANI's validation, monitoring and completion of the IRC Form 22, ensuring the correct deduction of the SIFIDE tax credit and the carry-forward of any remaining amounts to future years.
• Risk Mitigation: Proactive action in identifying and mitigating risks in case of a tax inspection, ensuring the company has all necessary evidence to justify the tax benefit enjoyed.

Our experience and knowledge allow us to optimise the SIFIDE tax credit, minimising the risk of rejection or corrections by the authorities. We invite you to visit our accounting for startups page to learn more about how we can support your innovative company.

9. Frequently Asked Questions about SIFIDE

9.1. How much can I save with SIFIDE?

SIFIDE allows you to save an amount corresponding to 32.5% of the year's eligible R&D expenses, plus 50% on the increase in investment compared to the average of the previous two years (limited to an increase in expenses of €1.5M). This amount is deducted directly from the IRC liability, representing a euro-for-euro saving on the tax payable.

9.2. Who can apply for SIFIDE?

All companies subject to Corporate Income Tax (IRC) in Portugal that carry out research and development activities. These are often technology, software, biotechnology, manufacturing companies, and startups with innovative projects.

9.3. How long can I use the SIFIDE credit?

The portion of the tax credit that cannot be deducted due to insufficient liability in the year it was generated can be carried forward and used in the following 8 tax years. This flexibility is crucial for companies with variable profits.

9.4. What is the application deadline?

The application must be submitted electronically to the National Innovation Agency (ANI), usually by the end of May of the year following that of the R&D expenses. For example, 2025 expenses must be applied for by May 2026.

9.5. Does SIFIDE accumulate with ICE?

Yes. SIFIDE is compatible with ICE (Incentive for Company Capitalisation) and with most other tax benefits and financial incentives. The non-cumulation rule only applies to the same eligible expenses, meaning it is possible to benefit from both, provided they relate to different calculation bases.

9.6. What happens if ANI does not approve my application?

If ANI does not validate the R&D nature of the projects or the eligibility of the expenses, the company will not be able to benefit from the tax credit. This is why rigorous preparation and, if necessary, the support of specialised consultants are fundamental to maximise the chances of approval.

10. Conclusion and Practical Recommendations

SIFIDE represents an unparalleled strategic opportunity for Portuguese companies investing in Research and Development. By allowing a direct deduction from the IRC liability, this incentive not only alleviates the tax burden but also fosters a virtuous cycle of innovation, competitiveness, and economic growth. Its relevance is growing in a global landscape where technological differentiation is a critical success factor.

10.1. Practical Recommendations

1. Annual Planning: Start planning your R&D activities and corresponding documentation from the beginning of the financial year. Real-time data collection and organisation are much more efficient than trying to reconstruct information retrospectively.
2. Time Recording System: Implement a robust system to record the hours dedicated by each team member to R&D projects. This is one of the pillars of personnel expense eligibility.
3. Detailed Technical Documentation: Maintain updated project sheets, with descriptions of objectives, methodologies, expected results, and progress records. ANI values clarity and depth of technical information.
4. Accounting Segregation: Create specific cost centres or analytical accounts for eligible R&D expenses. This facilitates the calculation and justification of expenses.
5. Legal and Tax Monitoring: Stay updated on legislative and regulatory changes to SIFIDE and the Investment Tax Code.
6. Specialised Consulting: Consider the support of SIFIDE-specialised consultants, such as HVR Business Consulting. Our expertise can be decisive in optimising the benefit, ensuring compliance, and minimising risks, allowing your team to focus on what they do best: innovating.

Investing in R&D is investing in the future of your company and the country. SIFIDE is the tax tool that transforms this investment into a tangible and immediate benefit. Do not fail to explore this incentive and integrate it into your fiscal management and innovation strategy.

For personalised support and to ensure your company makes the most of SIFIDE, contact HVR Business Consulting today. We are ready to help your innovation grow.

11. Sources and Legal References

• Decree-Law no. 162/2014, of 31 October (Investment Tax Code), Article 36.
• Decree-Law no. 292/2002, of 15 November.
• Ordinance no. 345-A/2014, of 31 December.
• Decree-Law no. 215/89, of 1 July (Tax Benefits Statute), Article 43.
• Decree-Law no. 442-B/88, of 30 November (Corporate Income Tax Code), Article 90.
• OECD Frascati Manual (Organisation for Economic Co-operation and Development) – Guidelines for Collecting and Reporting Data on Research and Experimental Development.
• National Innovation Agency (ANI) – SIFIDE Application Guide.
• Tax and Customs Authority (AT) – Relevant Binding Information and Circulars.